IP Library › Granted Patent US 10,875,839
Granted Patent B2
US 10,875,839 · App. 16/712,620 · Granted Dec 29, 2020

Somatostatin modulators and uses thereof

Inventors: Jian Zhao (San Diego, CA); Shimiao Wang (San Diego, CA); Yunfei Zhu (San Diego, CA)
Assignee: CRINETICS PHARMACEUTICALS, INC.
C07D401/04C07D401/14C07D405/14C07D413/14C07D471/04C07D498/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,875,839
App. No.
16/712,620
Granted
Dec 29, 2020
Kind
B2
Abstract

Described herein are compounds that are somatostatin modulators, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.

Claims (15)

1. A method of treating acromegaly in a human comprising orally administering to the human with acromegaly a pharmaceutical composition comprising a therapeutically effective amount of a compound that has the following structure:

or a pharmaceutically acceptable salt, or solvate thereof; and

at least one pharmaceutically acceptable excipient;

wherein the pharmaceutical composition is in the form of a tablet, a pill, or a capsule.

2. The method of claim 1 , wherein the pharmaceutical composition is in the form of a tablet.

3. The method of claim 1 , wherein the pharmaceutical composition is in the form of a capsule.

4. The method of claim 1 , wherein the composition is administered once per day, twice per day, three times per day, or four times per day.

5. The method of claim 4 , wherein the composition is administered once per day.

6. The method of claim 1 , wherein the composition is in the form of a capsule and is administered once per day.

7. The method of claim 1 , wherein the pharmaceutical composition comprises a therapeutically effective amount of a compound that has the following structure:

or a pharmaceutically acceptable salt thereof;

and a pharmaceutically acceptable excipient.

8. The method of claim 7 , wherein the composition is in the form of a capsule and is administered once per day.

9. The method of claim 7 , wherein the composition is in the form of a tablet and is administered once per day.

10. The method of claim 1 , wherein the composition is in the form of a tablet and is administered once per day.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2019
From: ZHAO, JIAN; HAN, SANGDON; KIM, SUN HEE; WANG, SHIMIAO; ZHU, YUNFEI
To: CRINETICS PHARMACEUTICALS, INC.
Reel/Frame 051269/0349 →
Continuity (6)
Continuation 16407031 · May 8, 2019
Continuation 15849409 · Dec 20, 2017
Continuation 15647758 · Jul 12, 2017
Provisional Application 62411338 · Oct 21, 2016
Provisional Application 62362493 · Jul 14, 2016
Related Publication 20200190053A1 · Jun 18, 2020
Cited By (2)
US 12,208,092 US 12,617,767